A Study to evaluate Efficacy, Safety, Tolerability and Effects of TAK-341 in the human body in patients with Multiple System Atrophy A Study to evaluate Efficacy, Safety, Tolerability and Effects of TAK-341 in the human body in patie ...
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous TAK-341 in Subjects With Multiple System Atrophy A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy, Safety, Tole ...
Multiple System Atrophy MedDRA version: 21.1;Level: PT;Classification code 10064060;Term: Multiple system atrophy;System Organ Class: 10029205 - Nervous system disorders;Therapeutic area: Diseases [C] - Nervous System Diseases [C10] Multiple System Atrophy MedDRA version: 21.1;Level: PT;Classification code 10064060;Term: Multiple s ...
Product Name: TAK-341 Product Code: TAK-341 INN or Proposed INN: Not assigned Other descriptive name: Human IgG1 monoclonal antibody against alpha-synucleinProduct Name: TAK-341 Product Code: TAK-341 INN or Proposed INN: Not assigned Other descriptive name: H ...
Takeda Development Center Americas, Inc.
NULL
Authorised-recruitment may be ongoing or finished
Female: yes Male: yes
138
Phase 2
United Kingdom;Italy;Japan;Denmark;Austria;Germany;Portugal;France;United States;Spain